This test is most useful if any of these apply to you.
Potassium is the mineral most tightly linked to whether your heart beats in a normal rhythm. When your level drifts even modestly outside a narrow window, the risk of dangerous arrhythmias, hospitalization, and death climbs measurably. That is why potassium is one of the few electrolytes where both too little and too much are genuinely dangerous, not just uncomfortable.
The number you see on a lab report reflects a small extracellular pool that your body defends aggressively through kidney excretion and moment-to-moment shifts between blood and cells. Understanding this pool matters most if you take blood pressure medications, have any kidney concerns, or want an early warning that your electrolyte balance is under strain.
Unlike many biomarkers where higher is always worse or lower is always better, potassium follows a U-shaped pattern. In a pooled analysis of about 1.2 million people followed for nearly seven years, the lowest mortality clustered between 4.0 and 4.5 mmol/L, with the specific nadir around 4.2 mmol/L. Compared with people at that sweet spot, all-cause mortality was roughly 22% higher at 5.5 mmol/L and about 50% higher at 3.0 mmol/L.
This is not a paradox once you understand what potassium does. It sets the electrical resting state of every heart muscle cell. Push it too high and the heart's electrical repolarization shortens, which can trigger arrhythmia and even cardiac arrest. Push it too low and the heart's action potential lengthens, which also destabilizes rhythm. So potassium is not a "higher good, lower bad" number. It is a narrow-target number, and both directions of drift carry cardiac cost.
The clearest reason to know your potassium is arrhythmia risk. In older adults, low serum potassium was associated with about 60% higher risk of supraventricular arrhythmias (irregular heartbeats originating above the ventricles). After a heart attack, high potassium was associated with roughly 2.3 times the risk of ventricular arrhythmias, the dangerous rhythms that cause sudden cardiac death.
In hospitalized general-ward patients, mortality began rising once potassium moved into the 4.6 to 5.0 mmol/L range, and it more than doubled above 5.5 mmol/L. In critical care with sepsis, an inflection point emerged at 4.4 mmol/L, above which 28-day death risk was roughly three times higher. Even variability inside the normal range matters: hospitalized patients whose potassium swung the most were about three times more likely to die during that admission than those whose values stayed steady.
Your kidneys handle about 90% of daily potassium removal, so any decline in kidney function eventually shows up as a rise in potassium. In older adults with advanced CKD (chronic kidney disease), the risk of death or needing dialysis was lowest when potassium sat in roughly the 4.0 to 5.0 mmol/L range, and climbed at both lower and higher values. In non-dialysis CKD, mortality rates were roughly 3 times higher at potassium below 3.5 mEq/L and 3.3 times higher at 6.0 mEq/L or above compared with normal ranges.
This matters even if you have never been told you have CKD. Kidney function declines gradually with age, and potassium is often one of the first electrolytes to shift when filtration slips. If you take medications that further limit potassium excretion, that hidden kidney reserve gets exposed.
In heart failure, both low and high potassium track worse outcomes, and the target window is even tighter. In a UK cohort of over 21,000 heart failure patients, mortality was roughly 2 times higher below 3.5 mmol/L and about 3 times higher at 6.0 mmol/L or above, compared with the 4.5 to 5.0 mmol/L reference range. A more recent individual patient meta-analysis of over 46,000 heart failure patients pointed to a slightly wider optimal window of about 4.2 to 5.0 mmol/L.
The wrinkle is that many core heart failure medications, including ACE inhibitors (a class of blood pressure drugs), ARBs (angiotensin receptor blockers, another blood pressure class), and mineralocorticoid receptor antagonists (aldosterone-blocking drugs like spironolactone), raise potassium as a side effect. Fear of hyperkalemia often leads to under-dosing of these life-extending medications, which itself worsens outcomes.
Higher dietary potassium intake lowers blood pressure in people with hypertension, with pooled reductions around 3.5 mmHg systolic and 2.0 mmHg diastolic. In hypertensive adults specifically, dose-response analyses suggest that a 50 mmol/day increase in urinary potassium (a marker of intake) is linked to a roughly 5 mmHg drop in systolic pressure. Higher intake was also linked to about 24% lower stroke risk in observational analyses.
This is where the two sides of potassium diverge. Dietary intake tends to help blood pressure and stroke risk in people with normal kidney handling. But in CKD, the same intake can push serum potassium into a danger zone. Two people can take the same action and get opposite results, which is one reason knowing your baseline number matters before making changes.
Potassium is unusually variable within the same person, even under standardized conditions. In one study of 1,170 outpatients tested repeatedly, about 12% of paired differences exceeded 0.5 mmol/L, and 44% of people whose average value was high had at least one normal reading, while 30% of people whose average was normal had at least one high reading. A single value can miss real problems or invent false ones.
For that reason, a trend across at least two or three tests carries more weight than any one reading. Get a baseline. If you are starting or adjusting a blood pressure medication, diuretic, or potassium supplement, retest in about 1 to 2 weeks, then again at 3 months. Once stable, retest at least annually, or every 3 to 6 months if you have CKD, heart failure, or are taking multiple potassium-affecting drugs. Watching whether your value drifts toward the edges of the safe zone is more useful than knowing where it sits today.
Potassium is notoriously easy to distort during sample handling. The problem is common enough that in one emergency department review, about 35% of initial elevated potassium results normalized on same-day repeat testing, and 69% of those false elevations showed hemolysis (red blood cells that ruptured in the tube, spilling their potassium). In one primary care cohort, 86% of initially elevated results were normal on repeat within 8 days.
If you get an unexpected result, especially one that doesn't fit your symptoms or ECG, the right first move is usually to repeat the test with clean collection technique before making treatment decisions.
An abnormal potassium is a starting point, not a diagnosis. The next question is why. That answer usually comes from combining potassium with a small set of companion tests and a careful medication review.
Evidence-backed interventions that affect your Potassium level
Potassium is best interpreted alongside these tests.
Potassium is included in these pre-built panels.